Navigation Links
DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial
Date:7/24/2014

d Mr. Bacha.

Clinical Trial Update

Our lead drug candidate, VAL-083, is currently undergoing a Phase I/II clinical trial in the United States as a potential new therapy for the treatment of refractory glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. 

We most recently provided an update at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) where it was disclosed that VAL-083 was safe and well tolerated at doses up to 30mg/m2 and that the next cohort (40mg/m2) had been opened for enrollment. DelMar's ASCO data presentation can be viewed on our website at: http://www.delmarpharma.com/products/publications/.

We are now pleased to confirm that the 40mg/m2 cohort is fully enrolled and, subject to completion of a safety review period, we plan to move forward with amending the protocol to allow us to treat patients at higher dosing levels. 

"To date, we have not seen evidence of a dose limiting toxicity in the initial patients at the 40mg/m2 dose. We believe it is prudent to pursue higher dosing levels with the goal of obtaining the maximum the level of drug that can be safely delivered to patients. This will enhance our likelihood of success in achieving our goal to commercialize VAL-083 as a new medicine for the treatment of refractory GBM patients who currently have no available therapeutic options."

About DelMar Pharmaceuticals

DelMar Pharmaceuticals was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The Company's lead asset, VAL-083, is currently undergoing clinical trials in the United States as a potential treatment for recurrent glioblastoma multiforme (GBM), the most common and aggressive form of brain can
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals Presents Interim Phase 1/2 Clinical Data for VAL-083 in Glioblastoma at Society for Neuro-Oncology Annual Meeting
2. DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
3. DelMar Pharmaceuticals Gives Quarterly Shareholder Update
4. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
5. DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
6. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
7. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
8. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
10. DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- RnRMarketResearch.com adds "CountryFocus: Healthcare, Regulatory and ... research report of 295 pages with latest updates, data ... The report " CountryFocus: Healthcare, Regulatory and Reimbursement ... and analysis of the healthcare, regulatory and reimbursement landscape ... key trends in the country,s healthcare market, and provides ...
(Date:3/30/2015)... RALEIGH, N.C. , March 30, 2015 /PRNewswire/ ... announced that the primary efficacy endpoint in the ... compared to placebo for the treatment of painful ... certain secondary endpoints showed statistically significant improvement over ... the product was observed.  The results of this ...
(Date:3/30/2015)... 30, 2015 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based ... announced its unaudited financial results for the fourth ... Financial HighlightsFor the quarter ended December 31, 2014: ... compared to the fourth quarter of 2013 ...
Breaking Medicine Technology:Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 2Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 3Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 4Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 5BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 11China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 12China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 13China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 14China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 15
... Corporation (Nasdaq: LMNX ) today announced financial ... September 30, 2010.  Financial and operating highlights include the ... $33.9 million, a 16 percent increase over the third ... system bringing affordable multiplexing to laboratories worldwide Third ...
... Nov. 4, 2010 eResearchTechnology, Inc. (ERT), (Nasdaq: ... services to the pharmaceutical, biotechnology, and medical device industries, ... ended September 30, 2010.  Unless otherwise noted, all comparative ... year ago.  The financial results for the third quarter ...
Cached Medicine Technology:Luminex Corporation Reports Third Quarter 2010 Results 2Luminex Corporation Reports Third Quarter 2010 Results 3Luminex Corporation Reports Third Quarter 2010 Results 4Luminex Corporation Reports Third Quarter 2010 Results 5Luminex Corporation Reports Third Quarter 2010 Results 6Luminex Corporation Reports Third Quarter 2010 Results 7Luminex Corporation Reports Third Quarter 2010 Results 8Luminex Corporation Reports Third Quarter 2010 Results 9ERT Reports Third Quarter 2010 Results 2ERT Reports Third Quarter 2010 Results 3ERT Reports Third Quarter 2010 Results 4ERT Reports Third Quarter 2010 Results 5ERT Reports Third Quarter 2010 Results 6ERT Reports Third Quarter 2010 Results 7ERT Reports Third Quarter 2010 Results 8ERT Reports Third Quarter 2010 Results 9ERT Reports Third Quarter 2010 Results 10ERT Reports Third Quarter 2010 Results 11ERT Reports Third Quarter 2010 Results 12ERT Reports Third Quarter 2010 Results 13
(Date:3/30/2015)... 30, 2015 The “Orthopedic ... EHR, Orthopedic PACS) By Applications (Orthopedic Surgery, ... Mode of Delivery] – Global Forecast to ... restraints and opportunities in North America, Europe, ... (RoW). , Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=94720371 ...
(Date:3/30/2015)... Daily sun exposure, stressors and environmental factors all ... and other giveaways of age. However, advances in surgical ... hit the pause button, delaying the impact of the ... hack to rejuvenate any facial feature. , The ... (AAFPRS) explores the intricacies of The Aging Face with ...
(Date:3/30/2015)... March 30, 2015 A new recruitment ... professionals search for their next career move. , Millions ... few years for those with skills in the booming ... http://www.1potato.com , is a jobs aggregator, pulling in opportunities ... and indexing them individually to help candidates find suitable ...
(Date:3/30/2015)... 30, 2015 National Nutrition Month ... their eating habits and commit to nutritious decisions that will ... According to a recent study from the U.S. Department of ... snack food. Making healthy snack choices needs to be an ... society constantly on the go. , Each day, millions of ...
(Date:3/29/2015)... Elfster.com, the top-rated Secret Santa generator, is proud to ... its gift exchange generator technology and extend its reach ... in Secret Santa online gift exchanges, the company is ... the opportunities as well. , "We are very pleased ... of Elster.com. "With Christmas and Valentine’s behind us, we ...
Breaking Medicine News(10 mins):Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4Health News:New AAFPRS Infographic Addresses Concerns and Provides Aging Face Solutions 2Health News:New Global Job Site Launched for Big Data and Analytics Job Seekers 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 3Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2
... hospitals deliver better and faster services in cardiac care ... annual meeting of the Institute for Operations Research and ... patients to achieve these results, and that average patients ... on Performance: Evidence from California Hospitals" is by Diwas ...
... more is needed to stem teen obesity, researchers say , ... States are becoming healthier places thanks to more nutritious food ... needed to combat teen obesity, a series of studies concludes. ... in a September supplement to the Journal of Adolescent ...
... ... - even in most remote regions of the U.S. and Canada - by taking advantage ... ... device manufacturers can have 100 percent visibility and tracking capabilities of their shipments - even ...
... DALLAS, Oct. 7 The Ensign Group, Inc. (Nasdaq: ... Golden Acres, an operating skilled nursing and independent living ... in Dallas, Texas. The acquisition was effective October 1, ... strategic acquisitions strengthen Ensign,s existing operational base and broaden ...
... 7 The recent localized government handout of samples ... Nukepills.com. Recent retail orders of Iosat(TM) Potassium Iodide have ... and medical facilities have surged as well for the ... iodide tablets was handed out to people residing within ...
... ... endpoint security, and IT GRC with industry leaders , ... Scottsdale, AZ (PRWEB) October 7, 2009 -- As cybercrime activity, workforce ... faced with the challenge of staying ahead of these threats. To enable companies to ...
Cached Medicine News:Health News:Specialty hospitals cherry-pick patients, exaggerate success, says INFORMS meeting paper 2Health News:Nutrition Still Not 'A' Grade in U.S. Schools: Studies 2Health News:Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 2Health News:Purolator USA Offers Advanced Tracking Capabilities for Medical Device Shipments 3Health News:The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 2Health News:The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 3Health News:Free Pills from Government Boost Potassium Iodide Sales 2Health News:Lumension Launches New Optimal IT Security Videocast Series 2Health News:Lumension Launches New Optimal IT Security Videocast Series 3
... Superior optics and workmanship are the hallmark ... temperature sensitivity in mind. The top (incident) ... illumination, eliminating shadows while remaining cool to ... are available with 10x to 44x zoom ...
... system expandability: the first inverted microscope to ... infinity space. Multi-port design enables optical input/output ... variety of illumination and detector equipment. Extendable ... an optional light source and other attachments ...
... The OLY-150 is an monochrome IR/DIC video camera. ... give you all the image quality and flexibility ... video cameras provide a high-resolution, real-time image of ... a video monitor or TV. You can even ...
... automatic fluorescence photomicrography system that greatly simply ... most difficult specimens. Designed with real life ... solution to the complex problem of fluorescence ... control, the system utilizes special programs designed ...
Medicine Products: